Autologous Stem Cell Transplantation: International Lupus Trial

NCT05063513 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Conditions

REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

Interventions

BIOLOGICAL: Autologous Hematopoietic Stem Cell Transplantation
DRUG: Rituximab

Sponsor

European Society for Blood and Marrow Transplantation

Collaborators

[object Object]